Ben-Hur H, Plonsky E, Berman V, Tendler Y, Gurevich P, Moriel E, Guy M, Sandler B, Zusman I
Department of Obstetrics and Gynecology, Kaplan Medical Center, Rehovot, Israel.
Eur J Gynaecol Oncol. 1999;20(4):306-10.
We have previously shown that vaccination with IgG generated against the soluble 53 kDa (s53) protein modified the splenic response to carcinogens. Here we studied whether such immunization could affect the splenic lymphatic system of the offspring.
Offspring of normal female rats or of rats immunized with anti-s53 IgG were exposed to a carcinogen (dimethyl-benz(a)antracene). After 4 months, their spleens were resected and evaluated immunohistochemically for lymphocyte proliferation, apoptosis and apoptosis-related proteins (Fas and Fas ligand), in tumor-free and tumor-bearing animals.
Spleens of progeny of unvaccinated rats had a significant decrease in the areas of follicles, germinal centers and the mantle layer after exposure to carcinogens, while maternal vaccination resulted in a significant expansion of the progeny's splenic follicles and germinal centers, the zones of B cell proliferation. The area of periarterial lymph sheaths (PALS) expanded in these offspring, reflecting activation of the T-zone. Maternal vaccination also resulted in a significant rise of Fas ligand-positive lymphocytes in the follicles and PALS of their tumor-free offspring. Tumorigenesis stimulated the Fas activity of B and T cells in the spleens, and this was much enhanced by maternal vaccination.
Maternal vaccination before pregnancy results in altered morphological and functional attributes of the splenic immune system of the offspring. This increased immunoreactivity could reduce the risk of tumors in progeny of vaccinated mothers.
我们之前已经表明,用针对可溶性53 kDa(s53)蛋白产生的IgG进行疫苗接种可改变脾脏对致癌物的反应。在此,我们研究了这种免疫接种是否会影响后代的脾脏淋巴系统。
正常雌性大鼠或用抗s53 IgG免疫的大鼠的后代暴露于致癌物(二甲基苯并(a)蒽)。4个月后,切除它们的脾脏,并对无肿瘤和有肿瘤的动物进行免疫组织化学评估,以检测淋巴细胞增殖、凋亡及凋亡相关蛋白(Fas和Fas配体)。
未接种疫苗的大鼠后代的脾脏在暴露于致癌物后,滤泡、生发中心和套层的面积显著减小,而母体接种疫苗导致后代脾脏滤泡和生发中心(B细胞增殖区域)显著扩大。这些后代的动脉周围淋巴鞘(PALS)面积扩大,反映了T细胞区的激活。母体接种疫苗还导致其无肿瘤后代的滤泡和PALS中Fas配体阳性淋巴细胞显著增加。肿瘤发生刺激了脾脏中B细胞和T细胞的Fas活性,而母体接种疫苗大大增强了这种活性。
怀孕前的母体接种疫苗会导致后代脾脏免疫系统的形态和功能属性发生改变。这种增强的免疫反应性可能会降低接种疫苗母亲后代患肿瘤的风险。